Results 131 to 140 of about 1,074 (253)

Comprehensive urinary metabolite profiles of workers exposed to aniline, 2,4-dimethylaniline, and 2-methylaniline. [PDF]

J Occup Health
Eitaki Y, Nakano M, Omae K, Takebayashi T.   +3 more
europepmc   +1 more source

A clash on the Toll pathway: competitive action between pesticides and zymosan A on components of innate immunity in <i>Apis mellifera</i>. [PDF]

Front Immunol, 2023
Sukkar D, Kanso A, Laval-Gilly P, Falla-Angel J.   +3 more
europepmc   +1 more source

Foreign Trade Tariff Statistics: 1972 [PDF]

, 1972

core  

Acid ceramidase overactivity drives ceramide loss, leading to atopic dry skin and Th2‐skewed immune polarization

The Journal of Pathology, Volume 269, Issue 2, Page 232-247, June 2026.
Abstract Ceramide deficiency in the stratum corneum (SC) is a key etiological factor in atopic dermatitis (AD). To clarify the direct role of SC ceramide depletion in impairing SC barrier and water‐holding functions and in initiating AD‐like skin symptoms and disease‐specific molecular alterations, we generated Tg mice overexpressing a mutant form of ...
Mariko Takada, Miho Sashikawa‐Kimura, Yusuke Ohno, Md Razib Hossain, Xiaonan Xie, Kazuhisa Iwabuchi, Mayumi Komine, Mamitaro Ohtsuki, Genji Imokawa   +8 more
wiley   +1 more source

Preliminary evaluation of ex vivo and in vivo skin permeability of aromatic amines. [PDF]

PLoS One
Yanagiba Y, Ono M, Toyooka T, Wang RS.
europepmc   +1 more source

Combination of teriflunomide and interferon as follow-up therapy after fingolimod-associated PML. [PDF]

Neurol Neuroimmunol Neuroinflamm, 2021
Fischer-Barnicol B, Oechtering J, Kuhle J, Lorscheider J, Kappos L, Derfuss T, Derfuss T.   +6 more
europepmc   +1 more source

Diagnosing Systemic Mastocytosis: State of the Art

International Journal of Laboratory Hematology, Volume 48, Issue 3, Page 551-560, June 2026.
ABSTRACT With the advent of effective multikinase and selective tyrosine kinase inhibitors in systemic mastocytosis, diagnosing this rare disease has been critical to improving patient morbidity and mortality. This state‐of‐the‐art review interprets the international diagnostic criteria, including differences between the WHO 5th edition classification ...
Anton Rets, Tracy I. George
wiley   +1 more source

Safety of disease-modifying therapies in multiple sclerosis: real-world data from the Austrian MS Treatment Registry (AMSTR). [PDF]

J Neurol
Monschein T, Untersteiner H, Ponleitner M, Krajnc N, Zrzavy T, Bsteh G, Rommer P, Kornek B, Enzinger C, Di Pauli F, Kraus J, Guger M, Leutmezer F, Berger T, Austrian MS Treatment Registry (AMSTR).   +14 more
europepmc   +1 more source

Sirt3 Genetically Engineered Apoptotic Bodies Alleviate Skeletal Aging by Limiting Aggravated NLRP3 Inflammasome Activation of Senescent Macrophages

Advanced Science, Volume 13, Issue 26, 8 May 2026.
The senescence of macrophages leads to a decrease in the expression of Sirtuin3 (Sirt3), which in turn aggravates the NLRP3 inflammasome activation and IL‐1β secretion, thereby promoting the aging‐related osteoporosis. Sirt3‐enriched apoptotic bodies (ABs‐Sirt3) generated through genetic editing approaches can alleviate skeletal aging by targeting ...
Yanglin Wu, Shifeng Ling, Jiayi Mao, Hongyi Wang, Bo Wang, Zhenjia Che, Wenguo Cui, Ming Cai   +7 more
wiley   +1 more source

In Vitro Synergistic Antiviral Effects of β-D-N4-hydroxycytidine and Teriflunomide in Combination against a Broad Range of RNA Viruses. [PDF]

J Med Virol
Sirihongthong T, Jitobaom K, Boonarkart C, Thongon S, Auewarakul P.   +4 more
europepmc   +1 more source